OpenAI领导对红皇后生物公司投资1 500万美元,以打击由AI操纵的生物武器。 OpenAI led a $15M investment in Red Queen Bio to combat AI-enabled biological weapons.

OpenAI在红皇后生物公司领导了1 500万美元的种子资金回合。 红皇后生物公司是一个生物技术启动项目,重点是防止人工智能化生物武器。 OpenAI has led a $15 million seed funding round in Red Queen Bio, a biotech startup focused on preventing AI-enabled biological weapons. 该公司由Hannu Rajaniemi共同创办,旨在利用人工智能和计算生物学发现和对付新出现的生物威胁。 The company, co-founded by Hannu Rajaniemi, aims to use AI and computational biology to detect and counter emerging biothreats. 这项投资反映了对人工智能双重用途潜力的日益关注,以及OpenAI在最近支持生物安全公司Valthos之后,更广泛地推动资助人工智能安全和安全倡议. The investment reflects growing concerns about AI’s dual-use potential and OpenAI’s broader push to fund AI safety and security initiatives, following its recent backing of biosecurity firm Valthos.